Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRVA
PRVA logo

PRVA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
21.790
Open
21.520
VWAP
21.55
Vol
952.63K
Mkt Cap
2.71B
Low
21.350
Amount
20.53M
EV/EBITDA(TTM)
38.98
Total Shares
126.01M
EV
2.34B
EV/OCF(TTM)
16.98
P/S(TTM)
1.24
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
Show More

Events Timeline

(ET)
2026-05-27
09:10:00
Privia Health Signs Agreement with NGBC to Enter New Jersey
select
2026-05-07 (ET)
2026-05-07
06:20:00
Company Reports Q1 Revenue of $603.8M, Exceeds Consensus
select

News

NASDAQ.COM
8.5
05-30NASDAQ.COM
PinnedRubicon Founders Increases Stake in Privia Health Group
  • Increased Holdings: Rubicon Founders purchased an additional 175,142 shares of Privia Health Group in Q1 2026, with an estimated trade value of $3.95 million, indicating a strong bullish sentiment as this stock now constitutes 88.92% of the fund's reportable AUM.
  • Strong Financial Performance: Privia Health Group reported $2.1 billion in revenue for 2025, marking a 22% year-over-year increase, while net income surged 59% to $22.9 million, reflecting robust market demand and profitability in the healthcare sector.
  • Healthy Balance Sheet: As of 2025, Privia Health's total assets stood at $1.4 billion against total liabilities of $578.4 million, with no debt, showcasing a solid financial position that supports future growth initiatives.
  • Optimistic Future Outlook: In Q1 2026, Privia Health's revenue rose 26% year-over-year, with full-year projections estimating around $2.4 billion, indicating that its solutions are effectively addressing unmet needs in the healthcare industry, thus presenting significant long-term investment potential.
Fool
6.5
05-30Fool
Rubicon Founders Increases Stake in Privia Health Group
  • Increased Holdings: Rubicon Founders LLC increased its stake in Privia Health Group by 175,142 shares in Q1 2026, with an estimated transaction value of $3.95 million, indicating a bullish outlook as the stock now represents 88.92% of its 13F reportable AUM.
  • Financial Performance: Privia Health reported a 22% year-over-year revenue growth in 2025, reaching $2.1 billion, with net income rising 59% to $22.9 million, showcasing its strong market position and demand for its services in the healthcare sector.
  • Market Expectations: In Q1 2026, Privia Health's revenue grew 26% year-over-year to $603.8 million, with full-year revenue projected to reach around $2.4 billion, indicating that its solutions are addressing unmet needs in the healthcare industry and boding well for future success.
  • Investment Value: The increase in holdings by Rubicon Founders positions Privia Health's stock as a core asset in its portfolio, reflecting a positive long-term investment outlook that may attract further investor interest.
seekingalpha
9.5
05-07seekingalpha
Privia Health Q1 Earnings Beat Expectations with Revenue Growth
  • Earnings Highlights: Privia Health reported a Q1 non-GAAP EPS of $0.19, missing expectations by $0.06, while revenue reached $603 million, reflecting a 25.6% year-over-year increase and exceeding estimates by $41.07 million, indicating strong market performance.
  • Guidance Update for 2026: The company maintained its full-year 2026 outlook for most metrics, raising the guidance range for Attributed Lives to between 1.6 million and 1.625 million, showcasing confidence in future growth prospects.
  • Operational Efficiency Improvement: It is expected that approximately 80% of Adjusted EBITDA will convert to free cash flow in 2026, enhancing the company's financial flexibility and supporting future investments.
  • Market Expansion Plans: Privia Health targets a 19.5% growth in Adjusted EBITDA for 2026 while expanding its footprint to 24 states, further solidifying its competitive position in the national market.
moomoo
5.0
05-01moomoo
Privia Health (PRVA.US) Director Plans to Sell $40.47 Million in Common Stock via Form 144
  • Share Sale Announcement: Matthew Shawn Morris intends to sell 1.63 million shares of Privia Health (PRVA.US) on May 1, with a total market value of approximately $40.47 million.

  • Reduction in Shareholding: Since February 26, 2026, Morris has reduced his shareholding in Privia Health by 24,338 shares, valued at approximately $608.36K.

NASDAQ.COM
5.0
03-22NASDAQ.COM
Privia Health CFO Sells Shares for Tax Obligations
  • Executive Stock Sale: David Mountcastle, CFO of Privia Health, sold 13,018 shares between March 12 and 13, 2026, for approximately $283,000 at an average price of $21.71 per share, representing 5.24% of his total direct holdings.
  • Tax Obligation Reason: The sale was strictly for tax withholding obligations related to the vesting of performance stock units, indicating that investors should not interpret this transaction as a negative signal for PRVA stock, but rather focus on the company's fundamentals.
  • Strong Financial Performance: Despite a 10% decline in PRVA's stock price in 2026, the company exceeded earnings expectations in its Q4 FY 2025 report, posting 7 cents per share, surpassing the 4-cent estimate and marking the highest year-over-year growth since Q3 2023.
  • Market Expansion Potential: Privia's acquisition of an Accountable Care Organization in late September 2025 added approximately 1.5 million customers, showcasing the company's growth potential in value-based operations, although analysts remain cautious about its future performance.
Fool
5.0
03-22Fool
Privia Health CFO Sells Shares for Tax Obligations
  • Transaction Overview: Privia Health CFO David Mountcastle sold 13,018 shares on March 12 and 13, 2026, for approximately $283,000, indicating a necessary action for tax obligations related to stock vesting.
  • Ownership Percentage Change: This transaction reduced Mountcastle's direct holdings by 5.24%, leaving him with 226,804 shares directly held, which represents a 0.18% stake in the company's outstanding shares, reflecting changes in ownership structure.
  • Stable Financial Performance: Despite a 10.15% decline in PRVA stock in 2026, the company exceeded earnings expectations in its Q4 FY 2025 report, posting earnings of $0.07 per share, significantly above the $0.04 estimate, demonstrating resilience in its fundamentals.
  • Customer Base Expansion: By acquiring an Accountable Care Organization (ACO), Privia gained approximately 1.5 million customers with medical plans such as Medicare, Medicare Advantage, and Medicaid, indicating growth potential in its value-based operations.
Wall Street analysts forecast PRVA stock price to rise
12 Analyst Rating
Wall Street analysts forecast PRVA stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
23.00
Averages
30.40
High
34.00
Current: 0.000
sliders
Low
23.00
Averages
30.40
High
34.00
Barclays
Andrew Mok
Equal Weight
downgrade
$25 -> $24
AI Analysis
2026-05-26
New
Reason
Barclays
Andrew Mok
Price Target
$25 -> $24
AI Analysis
2026-05-26
New
downgrade
Equal Weight
Reason
Barclays analyst Andrew Mok lowered the firm's price target on Privia Health to $24 from $25 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock moves post the Q1 reports are "durable." It continues to prefer managed care over facilities, saying inflation and commercial mix represent increasing drivers of provider earnings risk. Barclays adjusted ratings and targets in the group.
Canaccord
Buy
maintain
$35 -> $34
2026-05-08
Reason
Canaccord
Price Target
$35 -> $34
2026-05-08
maintain
Buy
Reason
Canaccord lowered the firm's price target on Privia Health to $34 from $35 and keeps a Buy rating on the shares. The firm said they posted another solid quarter which portends guidance will likely moove higher considering the company's high visibility.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PRVA
Unlock Now

Valuation Metrics

The current forward P/E ratio for Privia Health Group Inc (PRVA.O) is 23.75, compared to its 5-year average forward P/E of 47.68. For a more detailed relative valuation and DCF analysis to assess Privia Health Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
47.68
Current PE
23.75
Overvalued PE
336.93
Undervalued PE
-241.58

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-75.22
Current EV/EBITDA
-9233.86
Overvalued EV/EBITDA
934.66
Undervalued EV/EBITDA
-1085.11

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.84
Current PS
1.02
Overvalued PS
2.69
Undervalued PS
0.99

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is good stock to day trade today
Intellectia · 36 candidates
Price: $5.00 - $80.00Price Change Pct: $3.00 - $15.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
BSY logo
BSY
Bentley Systems Inc
11.64B
FIGS logo
FIGS
Figs Inc
2.05B
MGNI logo
MGNI
Magnite Inc
1.95B
CRSP logo
CRSP
CRISPR Therapeutics AG
5.93B
WWW logo
WWW
Wolverine World Wide Inc
1.64B
ARHS logo
ARHS
Arhaus Inc
1.31B
what about health tech stocks and robots?
Intellectia · 18 candidates
Market Cap: 50.00M - 50.00BWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ROK logo
ROK
Rockwell Automation Inc
47.26B
SYM logo
SYM
Symbotic Inc
36.98B
TER logo
TER
Teradyne Inc
36.32B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ZBRA logo
ZBRA
Zebra Technologies Corp
12.31B
DOCS logo
DOCS
Doximity Inc
7.50B

Whales Holding PRVA

O
OneDigital Investment Advisors, LLC
Holding
PRVA
+13.07%
3M Return
R
Riverbridge Partners, LLC
Holding
PRVA
+2.17%
3M Return
D
Durable Capital Partners, LP
Holding
PRVA
-3.63%
3M Return
V
Van Berkom and Associates Inc.
Holding
PRVA
-5.13%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Privia Health Group Inc (PRVA) stock price today?

The current price of PRVA is 21.51 USD — it has decreased -0.37

What is Privia Health Group Inc (PRVA)'s business?

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

What is the price predicton of PRVA Stock?

Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is30.40 USD with a low forecast of 23.00 USD and a high forecast of 34.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Privia Health Group Inc (PRVA)'s revenue for the last quarter?

Privia Health Group Inc revenue for the last quarter amounts to 603.85M USD, increased 25.78

What is Privia Health Group Inc (PRVA)'s earnings per share (EPS) for the last quarter?

Privia Health Group Inc. EPS for the last quarter amounts to 0.02 USD, decreased -33.33

How many employees does Privia Health Group Inc (PRVA). have?

Privia Health Group Inc (PRVA) has 1226 emplpoyees as of May 31 2026.

What is Privia Health Group Inc (PRVA) market cap?

Today PRVA has the market capitalization of 2.71B USD.